Medivolve Inc MEDVF

Healthcare Copper

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.

OTCPK:MEDVF - Post by User

Medivolve Inc > My opinion: HUGE ERROR in listing on NEO

<< Previous

Bullboard Posts

Next >>

Comment by Jasper66on Oct 16, 2020 2:21pm

129 Views

Post# 31729501

RE:RE:My opinion: HUGE ERROR in listing on NEO

Very good insight Holdme. The move to NEO seems to be a strategic move to release news to the US. After all, if your planning 2000 testing sites in the United States, then you better have a way to deciminate the news in the U.S. A lot has to do with our share price also. I'm sure Qsc management are keenly aware how this stock keeps on being held down. The changeover to NEO hopefully will slow the shorting. Once the share price rises, Qsc will most likely look at another stock exchange in the U.S.

<< Previous

Bullboard Posts

Next >>

DRI Healthcare stock drops 28% after executive changes